Cargando…

Does cefiderocol heteroresistance explain the discrepancy between the APEKS-NP and CREDIBLE-CR clinical trial results?

Detalles Bibliográficos
Autores principales: Choby, Jacob E, Ozturk, Tugba, Satola, Sarah W, Jacob, Jesse T, Weiss, David S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9743357/
https://www.ncbi.nlm.nih.gov/pubmed/35544102
http://dx.doi.org/10.1016/S2666-5247(21)00271-8
_version_ 1784848708244865024
author Choby, Jacob E
Ozturk, Tugba
Satola, Sarah W
Jacob, Jesse T
Weiss, David S
author_facet Choby, Jacob E
Ozturk, Tugba
Satola, Sarah W
Jacob, Jesse T
Weiss, David S
author_sort Choby, Jacob E
collection PubMed
description
format Online
Article
Text
id pubmed-9743357
institution National Center for Biotechnology Information
language English
publishDate 2021
record_format MEDLINE/PubMed
spelling pubmed-97433572022-12-12 Does cefiderocol heteroresistance explain the discrepancy between the APEKS-NP and CREDIBLE-CR clinical trial results? Choby, Jacob E Ozturk, Tugba Satola, Sarah W Jacob, Jesse T Weiss, David S Lancet Microbe Article 2021-12 2021-10-28 /pmc/articles/PMC9743357/ /pubmed/35544102 http://dx.doi.org/10.1016/S2666-5247(21)00271-8 Text en https://creativecommons.org/licenses/by-nc-nd/4.0/This is an Open Access article under the CC BY-NC-ND 4.0 license.
spellingShingle Article
Choby, Jacob E
Ozturk, Tugba
Satola, Sarah W
Jacob, Jesse T
Weiss, David S
Does cefiderocol heteroresistance explain the discrepancy between the APEKS-NP and CREDIBLE-CR clinical trial results?
title Does cefiderocol heteroresistance explain the discrepancy between the APEKS-NP and CREDIBLE-CR clinical trial results?
title_full Does cefiderocol heteroresistance explain the discrepancy between the APEKS-NP and CREDIBLE-CR clinical trial results?
title_fullStr Does cefiderocol heteroresistance explain the discrepancy between the APEKS-NP and CREDIBLE-CR clinical trial results?
title_full_unstemmed Does cefiderocol heteroresistance explain the discrepancy between the APEKS-NP and CREDIBLE-CR clinical trial results?
title_short Does cefiderocol heteroresistance explain the discrepancy between the APEKS-NP and CREDIBLE-CR clinical trial results?
title_sort does cefiderocol heteroresistance explain the discrepancy between the apeks-np and credible-cr clinical trial results?
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9743357/
https://www.ncbi.nlm.nih.gov/pubmed/35544102
http://dx.doi.org/10.1016/S2666-5247(21)00271-8
work_keys_str_mv AT chobyjacobe doescefiderocolheteroresistanceexplainthediscrepancybetweentheapeksnpandcrediblecrclinicaltrialresults
AT ozturktugba doescefiderocolheteroresistanceexplainthediscrepancybetweentheapeksnpandcrediblecrclinicaltrialresults
AT satolasarahw doescefiderocolheteroresistanceexplainthediscrepancybetweentheapeksnpandcrediblecrclinicaltrialresults
AT jacobjesset doescefiderocolheteroresistanceexplainthediscrepancybetweentheapeksnpandcrediblecrclinicaltrialresults
AT weissdavids doescefiderocolheteroresistanceexplainthediscrepancybetweentheapeksnpandcrediblecrclinicaltrialresults